Open House biologics discount contracts 2026: 12 Epoetin alfa and zeta
Original notice title
Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 12 Epoetin alfa und Epoetin zeta
Opportunity Score
Why this score?
Opportunity
0 / 100
Complexity
0 / 100
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Tender facts
- Contracting authority
- Techniker Krankenkasse
- Country
- Germany
- CPV
- 33600000 - Pharmaceutical products
- Deadline
- Dec 30, 2026
AI tender analysis
Tenderwize prepares an AI analysis of this tender based on the TED notice and procurement documents: scope of work, key requirements, eligibility criteria, risks and questions for the buyer. The analysis is generated when the tender is opened.
Buyer
Location
Hamburg, DEU
Website
Identifier
992-80116-93
Activity
Health
Lots (1)
LOT-0001
Open House Biologika Rabattverträge 2026 - 12 Epoetin alfa und Epoetin zeta
Die TK verfolgt das Ziel, mit allen geeigneten pharmazeutischen Unternehmern Rabattverträge nach § 130a Abs. 8 SGB V zu Epoetin alfa und Epoetin zeta zu schließen.
Location
Duration
Category
Award details
Die TK verfolgt das Ziel, mit allen geeigneten pharmazeutischen Unternehmern Rabattverträge nach § 130a Abs. 8 SGB V zu Epoetin alfa und Epoetin zeta zu schließen.
Procurement Details
- Publication date
- 17 Nov 2026
- Languages
- German
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 800819-2026
Documents (1)
Similar tenders
Czechia – Pharmaceutical products – Léčivý přípravek ATC skupiny L04AC24 s účinnou látkou MIRIKIZUMAB
Germany – Pharmaceutical products – Open-House-Biologika-Rabattverträge 2026-08 - Filgrastim
Poland – Pharmaceutical products – „Dostawa produktów leczniczych w ramach importu docelowego w podziale na 6 części; DZPUCK.262.210.2026”
Poland – Pharmaceutical products – Sukcesywne dostawy leków oraz innych materiałów do Apteki Szpitalnej z prawem opcji
Belgium – Pharmaceutical products – Fourniture d'Eltrombopag
Czechia – Pharmaceutical products – Léčivý přípravek ATC skupiny L03AB13 s účinnou látkou PEGINTERFERON BETA-1A
Opportunity Score
Why this score?
Opportunity
0 / 100
Complexity
0 / 100
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications